aromasil has been researched along with trelstar in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 11 (84.62) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Bello, A; Buchan, P; Di Salle, E; Jannuzzo, MG; Pirotta, N; Spinelli, R | 1 |
| Rabaglio, M; Ruepp, B | 1 |
| Coates, AS; Colleoni, M; Fleming, GF; Francis, PA; Gelber, RD; Goldhirsch, A; Maibach, R; Pagani, O; Price, KN; Rabaglio, M; Regan, MM; Ruepp, B; Walley, BA | 1 |
| Bernhard, J; Bonnefoi, HR; Burstein, HJ; Ciruelos, E; Coates, AS; Colleoni, M; Crivellari, D; Fleming, GF; Francis, PA; Gelber, RD; Geyer, CE; Giobbie-Hurder, A; Goldhirsch, A; Gomez, HL; Láng, I; Luo, W; Maibach, R; Martino, S; Pagani, O; Perez, EA; Pinotti, G; Price, KN; Puglisi, F; Rabaglio-Poretti, M; Regan, MM; Ribi, K; Ruepp, B; Ruhstaller, T; Stearns, V; Tondini, C; Viale, G; Walley, BA; Winer, EP | 1 |
| Rugo, HS | 1 |
| Chekhun, VF; Grabovoy, AN; Lukyanova, NY; Svintsitsky, VS; Tarasova, TO; Tkalia, IG; Todor, IN; Vorobyova, LI | 1 |
| Hershman, DL | 1 |
| Grabovoy, AN; Svintsitsky, VS; Tarasova, TO; Tkalia, IG; Vorobyova, LI | 1 |
| de la Vega, M; Díaz Cantón, E; Greco, M; Recondo, G; Valsecchi, ME | 1 |
| Avella, A; Azaro, A; Bellet, M; Bohn, U; Catalán, G; Catalán, R; Ciruelos, E; Climent, MA; Ferrer, R; Fleming, GF; Francis, PA; González-Martin, A; Gray, KP; Láng, I; Lluch, A; Morales, J; Price, KN; Rajasekaran, A; Regan, MM; Vázquez, J | 1 |
| Bellet, M; Bernhard, J; Burstein, HJ; Ciruelos, E; Coates, AS; Colleoni, M; Fleming, GF; Francis, PA; Gelber, RD; Goldhirsch, A; Karlsson, P; Kerbrat, P; Lluch, A; Lombardi, D; Luo, W; Neven, P; Parmar, V; Pavesi, L; Perelló, A; Price, KN; Puglisi, F; Regan, MM; Ribi, K; Ruhstaller, T; Tondini, C; Torres, R; Visini, M | 1 |
| Coates, AS; Colleoni, M; Di Leo, A; Fleming, GF; Francis, PA; Gelber, RD; Goldhirsch, A; Gómez, HL; Láng, I; Pagani, O; Pinotti, G; Regan, MM; Tondini, C; Viale, G; Walley, BA | 1 |
| Petit, T | 1 |
2 review(s) available for aromasil and trelstar
| Article | Year |
|---|---|
Anti-Hormonal Therapies for Premenopausal Patients--What did we Learn from the TEXT/SOFT Trials?
Topics: Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Drug Therapy, Combination; Estrogen Antagonists; Female; Humans; Multicenter Studies as Topic; Ovary; Premenopause; Randomized Controlled Trials as Topic; Tamoxifen; Triptorelin Pamoate | 2015 |
[Endocrine adjuvant treatment specific features for young breast cancer women].
Topics: Adult; Amenorrhea; Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Goserelin; Humans; Luteolytic Agents; Neoplasm Recurrence, Local; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Tamoxifen; Time Factors; Triptorelin Pamoate | 2019 |
5 trial(s) available for aromasil and trelstar
| Article | Year |
|---|---|
Estrogen suppression in premenopausal women following 8 weeks of treatment with exemestane and triptorelin versus triptorelin alone.
Topics: Adult; Androstadienes; Antineoplastic Agents; Breast Neoplasms; Double-Blind Method; Estradiol; Estrone; Female; Gonadotropins; Humans; Ovary; Premenopause; Triptorelin Pamoate; Young Adult | 2009 |
Adjuvant treatment of premenopausal women with endocrine-responsive early breast cancer: design of the TEXT and SOFT trials.
Topics: Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Humans; Ovariectomy; Ovary; Premenopause; Research Design; Statistics as Topic; Tamoxifen; Triptorelin Pamoate | 2013 |
Adjuvant exemestane with ovarian suppression in premenopausal breast cancer.
Topics: Adult; Androstadienes; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Estradiol; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Mastectomy; Middle Aged; Osteoporosis; Premenopause; Quality of Life; Tamoxifen; Triptorelin Pamoate | 2014 |
Twelve-Month Estrogen Levels in Premenopausal Women With Hormone Receptor-Positive Breast Cancer Receiving Adjuvant Triptorelin Plus Exemestane or Tamoxifen in the Suppression of Ovarian Function Trial (SOFT): The SOFT-EST Substudy.
Topics: Adult; Androstadienes; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Estradiol; Estrogens; Estrone; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Ovary; Tamoxifen; Triptorelin Pamoate | 2016 |
Adjuvant Tamoxifen Plus Ovarian Function Suppression Versus Tamoxifen Alone in Premenopausal Women With Early Breast Cancer: Patient-Reported Outcomes in the Suppression of Ovarian Function Trial.
Topics: Adult; Androstadienes; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Humans; Lymphatic Metastasis; Ovary; Premenopause; Quality of Life; Self Report; Tamoxifen; Triptorelin Pamoate | 2016 |
6 other study(ies) available for aromasil and trelstar
| Article | Year |
|---|---|
Death due to liver failure during endocrine therapy for premenopausal breast cancer.
Topics: Adult; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemical and Drug Induced Liver Injury; Diphenhydramine; Drug Synergism; Estrogen Receptor Modulators; Fatal Outcome; Female; Hepatitis, Alcoholic; Humans; Hypnotics and Sedatives; Liver Failure, Acute; Middle Aged; Premenopause; Self Medication; Tamoxifen; Triptorelin Pamoate | 2010 |
Hormone therapy in premenopausal women with early-stage breast cancer.
Topics: Androstadienes; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Tamoxifen; Triptorelin Pamoate | 2014 |
Increase of antitumor activity of cisplatin using agonist of gonadotropin-realising hormone and inhibitor of aromatase on the model of ascites ovarian tumor.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Androstadienes; Animals; Antineoplastic Agents; Apoptosis; Aromatase Inhibitors; Ascites; Cell Proliferation; Cisplatin; Disease Models, Animal; Drug Synergism; Female; Gonadotropin-Releasing Hormone; Immunoenzyme Techniques; Ovarian Neoplasms; Rats; Rats, Wistar; Triptorelin Pamoate; Tumor Cells, Cultured | 2014 |
Perfecting breast-cancer treatment--incremental gains and musculoskeletal pains.
Topics: Androstadienes; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Tamoxifen; Triptorelin Pamoate | 2015 |
The antitumor efficacy of cisplatin in combination with triptorelin and exemestane therapy for an ovarian cancer ascites model in Wistar rats.
Topics: Androstadienes; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Ascites; Cisplatin; Female; Ovarian Neoplasms; Ovary; Rats; Rats, Wistar; Triptorelin Pamoate; Vascular Endothelial Growth Factor A | 2015 |
Absolute Improvements in Freedom From Distant Recurrence to Tailor Adjuvant Endocrine Therapies for Premenopausal Women: Results From TEXT and SOFT.
Topics: Androstadienes; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Female; Humans; Neoplasm Recurrence, Local; Ovariectomy; Ovary; Premenopause; Randomized Controlled Trials as Topic; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Triptorelin Pamoate | 2020 |